Correlation between impedance cardiography and B-type natriuretic peptide levels in dyspneic patients.

BACKGROUND Both serum measurements of B-type natriuretic peptide (BNP) and impedance cardiography (ICG) are used to evaluate patients for congestive heart failure (CHF) in the Emergency Department (ED), but the agreement between the data obtained by these two methods remains uncertain. STUDY OBJECTIVES We sought to measure the correlation between BNP levels and ICG measurements in patients presenting to the ED with dyspnea, and compare the diagnostic accuracy of each method in diagnosing CHF. METHODS We performed a prospective observational study of a convenience sample of patients presenting to the ED with dyspnea and being evaluated for CHF as a cause of their symptoms. An ICG measurement was obtained on each patient and the correlation between BNP level and the ICG parameters cardiac index (CI), systemic vascular resistance (SVR), and thoracic fluid content (TFC) was measured. To further quantify the diagnostic accuracy of ICG and BNP, we then constructed receiver operating characteristic curves based on discharge diagnosis of CHF and compared the area under the curve (AUC) of each test. RESULTS Out of 54 patients enrolled, correlation was poor between BNP and CI (Spearman's ρ = -.07, p = 0.64) and between BNP and SVR (Spearman's ρ = -.10, p = 0.46), but moderate between BNP and TFC (Spearman's ρ = .32, p = 0.02); a wide degree of scatter was seen in all correlations. BNP levels showed the best diagnostic accuracy for a discharge diagnosis of CHF, with an AUC of .77 (95% confidence interval .59-.95), whereas CI had an AUC of .72 (95% confidence interval .55-.88). CONCLUSION We found limited correlation between BNP levels and ICG parameters, suggesting that, in our population, the two tests may not consistently give similar information. BNP level and CI both provided only fair diagnostic accuracy for discharge diagnosis of CHF.

[1]  J. Hollander,et al.  Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[2]  S. Palta,et al.  New diagnostic modalities in the diagnosis of heart failure. , 2004, Journal of the National Medical Association.

[3]  P. Clopton,et al.  Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients. , 2005, American journal of hypertension.

[4]  L. Morrison,et al.  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. , 2002, Annals of emergency medicine.

[5]  N. Lakkis,et al.  Usefulness of B-type natriuretic peptide levels to predict left ventricular filling pressures in patients with body mass index >35, 31 to 35, and < or =30 kg/m2. , 2007, The American journal of cardiology.

[6]  G. Tamagno,et al.  Bioimpedance analysis and plasma B-type natriuretic peptide assay may cooperate in diagnosing and managing heart failure , 2006, Acta cardiologica.

[7]  F. Sebat,et al.  Utility of impedance cardiography to determine cardiac vs. noncardiac cause of dyspnea in the emergency department. , 2004, Congestive heart failure.

[8]  R. McKelvie,et al.  Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care. , 2008, Clinical biochemistry.

[9]  A. Maisel,et al.  B-type natriuretic peptide in the emergency department: a valuable diagnostic aid. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[10]  J. Hollander,et al.  Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study. , 2005, Annals of emergency medicine.

[11]  Richard L Summers,et al.  Use of noninvasive hemodynamics to aid decision making in the initiation and titration of neurohormonal agents. , 2004, Congestive heart failure.

[12]  C. Ng,et al.  Utility of impedance cardiography for dyspneic patients in the ED. , 2007, The American journal of emergency medicine.

[13]  Eric Schwam,et al.  B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal. , 2004, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[14]  J. Hollander,et al.  B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study , 2002, Circulation.

[15]  D. Guss,et al.  Utility of impedance cardiography to improve physician estimation of hemodynamic parameters in the emergency department. , 2005, Congestive heart failure.

[16]  D. Muthu,et al.  Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure , 2009 .

[17]  R. Kazanegra,et al.  Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. , 2004, Congestive heart failure.

[18]  W Frank Peacock,et al.  Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[19]  Milton Packer,et al.  Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. , 2006, Journal of the American College of Cardiology.

[20]  K. Vijayaraghavan,et al.  Association of impedance cardiography parameters with changes in functional and quality-of-life measures in patients with chronic heart failure. , 2004, Congestive heart failure.